112 related articles for article (PubMed ID: 6683273)
1. Progesterone receptor replenishment in T47D human breast cancer cells. Roles of protein synthesis and hormone metabolism.
Horwitz KB; Mockus MB; Pike AW; Fennessey PV; Sheridan RL
J Biol Chem; 1983 Jun; 258(12):7603-10. PubMed ID: 6683273
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-insensitive progesterone receptors in a human breast cancer cell line: characterization of receptors and of a ligand exchange assay.
Mockus MB; Lessey BA; Bower MA; Horwitz KB
Endocrinology; 1982 May; 110(5):1564-71. PubMed ID: 7200421
[TBL] [Abstract][Full Text] [Related]
3. Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells.
Wei LL; Krett NL; Francis MD; Gordon DF; Wood WM; O'Malley BW; Horwitz KB
Mol Endocrinol; 1988 Jan; 2(1):62-72. PubMed ID: 3398843
[TBL] [Abstract][Full Text] [Related]
4. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.
Horwitz KB; Mockus MB; Lessey BA
Cell; 1982 Mar; 28(3):633-42. PubMed ID: 7200400
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptors in human breast cancer. Stoichiometric translocation and nuclear receptor processing.
Mockus MB; Horwitz KB
J Biol Chem; 1983 Apr; 258(8):4778-83. PubMed ID: 6833276
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
Nardulli AM; Katzenellenbogen BS
Endocrinology; 1988 Apr; 122(4):1532-40. PubMed ID: 3345726
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells.
Chalbos D; Rochefort H
J Biol Chem; 1984 Jan; 259(2):1231-8. PubMed ID: 6229532
[TBL] [Abstract][Full Text] [Related]
8. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
Horwitz KB
Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
[TBL] [Abstract][Full Text] [Related]
9. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
10. Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing.
Wei LL; Sheridan PL; Krett NL; Francis MD; Toft DO; Edwards DP; Horwitz KB
Biochemistry; 1987 Sep; 26(19):6262-72. PubMed ID: 3689774
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
Vignon F; Bardon S; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
[TBL] [Abstract][Full Text] [Related]
12. Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.
Sarup JC; Rao KV; Fox CF
Cancer Res; 1988 Sep; 48(18):5071-8. PubMed ID: 3044580
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
Horwitz KB; Freidenberg GR
Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor replenishment during sustained progesterone treatment in the hamster uterus.
Okulicz WC
Endocrinology; 1986 Jun; 118(6):2488-94. PubMed ID: 3698920
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation. Evidence for a non-hormone binding receptor precursor.
Mullick A; Katzenellenbogen BS
J Biol Chem; 1986 Oct; 261(28):13236-46. PubMed ID: 3759961
[TBL] [Abstract][Full Text] [Related]
16. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
Hurd C; Nag K; Khattree N; Alban P; Dinda S; Moudgil VK
Mol Cell Biochem; 1999 Sep; 199(1-2):49-56. PubMed ID: 10544951
[TBL] [Abstract][Full Text] [Related]
17. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
18. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
Attardi B; Palumbo LA
Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
[TBL] [Abstract][Full Text] [Related]
19. Effect of the progestagen R5020 (promegestone) and of progesterone on the uptake and on the transformation of estrone sulfate in the MCF-7 and T-47d human mammary cancer cells: correlation with progesterone receptor levels.
Pasqualini JR; Varin C; Nguyen BL
Cancer Lett; 1992 Sep; 66(1):55-60. PubMed ID: 1451096
[TBL] [Abstract][Full Text] [Related]
20. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
